Literature DB >> 8646412

Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury.

C A Herbert1, M J Arthur, C Robinson.   

Abstract

1. We have studied the release of gelatin-degrading enzymes from isolated sheets of bronchial mucosa in the presence and absence of eosinophils. 2. Isolated sheets of bovine bronchial mucosa released gelatin-degrading activity in similar amounts from both the apical and basolateral aspects of the tissue. Gelatinolytic activity could not be increased by treatment of the mucosal sheets with calcium ionophore, A23187. 3. The activity of the released gelatinases could be inhibited by chelation of divalent cations or by the matrix metalloproteinase inhibitors, BB-94 and BB-250. However, inhibitors of serine proteinases, or of cysteine proteinases were without effect. In zymography, major bands of gelatin-degrading activity consistent with gelatinases A and B were identified. 4. Addition of guinea-pig eosinophils to the basolateral aspect of bronchial mucosa for 60 min resulted in an increase in the gelatinolytic activity of the conditioned medium, irrespective of whether the eosinophils were stimulated with ionophore A23187 or not. However, only ionophore-stimulated eosinophils reacted to produce sufficient tissue damage to increase the transepithelial flux of serum albumin. 5. Purified eosinophils were a poor source of gelatinolytic activity, indicating that when interacting with the bronchial mucosa their effect is to increase the apparent release and/or activation of gelatinases derived from the airway mucosa. 6. After organomercurial activation, recombinant human progelatinase A increased the permeability of the bronchial mucosa to mannitol. However, the activity of enzyme and duration of exposure required to do this were greater than the amounts of gelatinase activity detected during eosinophil-mediated injury. Sheets of airway mucosa were also resistant to injury evoked by high concentrations of hydrogen peroxide or plasmin. 7. Collectively, these results suggest that if gelatinases are involved in eosinophil-mediated injury and repair of the bronchial mucosa, they require other mediators to act in concert to bring about outright epithelial cell detachment. This does not preclude the possibility that gelatinases are crucial in rendering the airway mucosa hyperfragile.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8646412      PMCID: PMC1909334          DOI: 10.1111/j.1476-5381.1996.tb15242.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1.

Authors:  C A Herbert; C M King; P C Ring; S T Holgate; G A Stewart; P J Thompson; C Robinson
Journal:  Am J Respir Cell Mol Biol       Date:  1995-04       Impact factor: 6.914

2.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema.

Authors:  M S Dunnill; G R Massarella; J A Anderson
Journal:  Thorax       Date:  1969-03       Impact factor: 9.139

3.  Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  Human progelatinase A can be activated by matrilysin.

Authors:  T Crabbe; B Smith; J O'Connell; A Docherty
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

5.  Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs.

Authors:  M P D'Ortho; P H Jarreau; C Delacourt; I Macquin-Mavier; M Levame; S Pezet; A Harf; C Lafuma
Journal:  Am J Physiol       Date:  1994-03

6.  Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes.

Authors:  J G Lyons; B Birkedal-Hansen; M C Pierson; J M Whitelock; H Birkedal-Hansen
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

7.  A comparison of the effects of polyarginine and stimulated eosinophils on the responsiveness of the bovine isovolumic bronchial segment preparation.

Authors:  T Omari; M P Sparrow; M K Church; S T Holgate; C Robinson
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  Isolation and characterization of a high molecular weight type IV collagenase isolated from human carcinoma tissue.

Authors:  T T Tsuda; A Kodama; M Yamamura; S Matsuzaki; M Tsuda
Journal:  FEBS Lett       Date:  1993-03-15       Impact factor: 4.124

9.  Expression of matrix metalloproteinase-2 and -9 during early human wound healing.

Authors:  T Salo; M Mäkelä; M Kylmäniemi; H Autio-Harmainen; H Larjava
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

10.  In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2.

Authors:  M S Mulligan; P E Desrochers; A M Chinnaiyan; D F Gibbs; J Varani; K J Johnson; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more
  1 in total

1.  Inhibition of gelatinase activity in human airway epithelial cells and fibroblasts by dexamethasone and beclomethasone.

Authors:  J E Carver; W A Galloway; C Robinson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.